154 related articles for article (PubMed ID: 21878090)
1. Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors.
Durrant JD; McCammon JA
BMC Pharmacol; 2011 Aug; 11():9. PubMed ID: 21878090
[TBL] [Abstract][Full Text] [Related]
2. High resolution crystal structure of a key editosome enzyme from Trypanosoma brucei: RNA editing ligase 1.
Deng J; Schnaufer A; Salavati R; Stuart KD; Hol WG
J Mol Biol; 2004 Oct; 343(3):601-13. PubMed ID: 15465048
[TBL] [Abstract][Full Text] [Related]
3. Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei.
Amaro RE; Schnaufer A; Interthal H; Hol W; Stuart KD; McCammon JA
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17278-83. PubMed ID: 18981420
[TBL] [Abstract][Full Text] [Related]
4. Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.
Durrant JD; Hall L; Swift RV; Landon M; Schnaufer A; Amaro RE
PLoS Negl Trop Dis; 2010 Aug; 4(8):e803. PubMed ID: 20808768
[TBL] [Abstract][Full Text] [Related]
5. Designing novel inhibitors of Trypanosoma brucei.
Demir O; Amaro RE
Methods Mol Biol; 2013; 993():231-43. PubMed ID: 23568474
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of Trypanosoma brucei RNA editing ligase reveals regions critical for interaction with KREPA2.
Mehta V; Sen R; Moshiri H; Salavati R
PLoS One; 2015; 10(3):e0120844. PubMed ID: 25790471
[TBL] [Abstract][Full Text] [Related]
7. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
[TBL] [Abstract][Full Text] [Related]
8. The structure of the C-terminal domain of the largest editosome interaction protein and its role in promoting RNA binding by RNA-editing ligase L2.
Park YJ; Budiarto T; Wu M; Pardon E; Steyaert J; Hol WG
Nucleic Acids Res; 2012 Aug; 40(14):6966-77. PubMed ID: 22561373
[TBL] [Abstract][Full Text] [Related]
9. African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase.
West RA; O'Doherty OG; Askwith T; Atack J; Beswick P; Laverick J; Paradowski M; Pennicott LE; Rao SPS; Williams G; Ward SE
Eur J Med Chem; 2017 Dec; 141():676-689. PubMed ID: 29107420
[TBL] [Abstract][Full Text] [Related]
10. Is the Trypanosoma brucei REL1 RNA ligase specific for U-deletion RNA editing, and is the REL2 RNA ligase specific for U-insertion editing?
Gao G; Simpson L
J Biol Chem; 2003 Jul; 278(30):27570-4. PubMed ID: 12748175
[TBL] [Abstract][Full Text] [Related]
11. Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screening.
Pedró-Rosa L; Buckner FS; Ranade RM; Eberhart C; Madoux F; Gillespie JR; Koh CY; Brown S; Lohse J; Verlinde CL; Fan E; Bannister T; Scampavia L; Hol WG; Spicer T; Hodder P
J Biomol Screen; 2015 Jan; 20(1):122-30. PubMed ID: 25163684
[TBL] [Abstract][Full Text] [Related]
12. Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode.
Spinks D; Smith V; Thompson S; Robinson DA; Luksch T; Smith A; Torrie LS; McElroy S; Stojanovski L; Norval S; Collie IT; Hallyburton I; Rao B; Brand S; Brenk R; Frearson JA; Read KD; Wyatt PG; Gilbert IH
ChemMedChem; 2015 Nov; 10(11):1821-36. PubMed ID: 26395087
[TBL] [Abstract][Full Text] [Related]
13. The trypanosome alternative oxidase: a potential drug target?
Menzies SK; Tulloch LB; Florence GJ; Smith TK
Parasitology; 2018 Feb; 145(2):175-183. PubMed ID: 27894362
[TBL] [Abstract][Full Text] [Related]
14. Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sickness.
Koh CY; Kim JE; Wetzel AB; de van der Schueren WJ; Shibata S; Ranade RM; Liu J; Zhang Z; Gillespie JR; Buckner FS; Verlinde CL; Fan E; Hol WG
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2775. PubMed ID: 24743796
[TBL] [Abstract][Full Text] [Related]
15. A novel high-throughput activity assay for the Trypanosoma brucei editosome enzyme REL1 and other RNA ligases.
Zimmermann S; Hall L; Riley S; Sørensen J; Amaro RE; Schnaufer A
Nucleic Acids Res; 2016 Feb; 44(3):e24. PubMed ID: 26400159
[TBL] [Abstract][Full Text] [Related]
16. Functional complementation of Trypanosoma brucei RNA in vitro editing with recombinant RNA ligase.
Gao G; Simpson AM; Kang X; Rogers K; Nebohacova M; Li F; Simpson L
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4712-7. PubMed ID: 15781861
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design.
Pizarro JC; Hills T; Senisterra G; Wernimont AK; Mackenzie C; Norcross NR; Ferguson MA; Wyatt PG; Gilbert IH; Hui R
PLoS Negl Trop Dis; 2013; 7(10):e2492. PubMed ID: 24147171
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Virtual Screening and Biochemical Evaluation for the Identification of Novel Trypanosoma brucei Aldolase Inhibitors.
Ferreira LLG; Ferreira RS; Palomino DL; Andricopulo AD
Curr Top Med Chem; 2018; 18(5):397-405. PubMed ID: 29701141
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery: Fat-free proteins kill parasites.
Cross GA
Nature; 2010 Apr; 464(7289):689-90. PubMed ID: 20360728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
